Alnylam Pharmaceuticals Inc. (ALNY)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

1,105,000 $209,883,700 2.84%
2.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

345,000 $65,529,300 1.55%
3.
Casdin Capital

Eli Casdin

280,000 $53,183,200 +4% 4.64%
4.
D E Shaw

D. E. Shaw

248,272 $47,156,783 +8% 0.04%
5.
Polar Capital

Brian Ashford-Russell And Tim Woolley

235,000 $44,635,900 -25% 0.3%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$71.87 297,501 Large Shareholder 10,554,134 2017-05-31 Filing
$65.35 11,500 Officer 11,500 2017-05-30 Filing
$37.00 27,900 Director 27,900 2016-10-13 Filing
$58.36 2,000 Director 4,000 2016-03-09 Filing
$69.75 205,030 Large Shareholder 10,256,633 2016-02-01 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$185.32 240 Officer 4,345 2023-08-07 Filing
$184.65 814 Officer 4,585 2023-08-07 Filing
$183.58 3,112 Officer 5,399 2023-08-07 Filing
$189.31 164 Officer 8,511 2023-08-04 Filing
$188.40 15 Officer 8,675 2023-08-04 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 16,497,551 $3,133,560,610 0.6%
2. 12,492,500 $2,372,825,498 0.19%
3. 11,626,223 $2,208,284,796 0.05%
4. 8,392,216 $1,594,017,507 1.4%
5. 8,386,162 $1,592,867,612 0.04%
News See All